A Study of ARRY-438162 in Patients With Rheumatoid Arthritis

Summary

This is a Phase 2 study, involving a 12-week treatment period, designed to evaluate the effectiveness of investigational study drug ARRY-438162 in treating rheumatoid arthritis in patients on stable doses of methotrexate, and to further evaluate the safety of the study drug. Approximately 200 patients from the US, Argentina, Brazil, Hungary, Peru, Poland and Romania will be enrolled in this study.

Timeline

Start

2008-03

Primary completion

2009-07

Completion

2009-07

Drugs

Indications